New Atlas: Oral insulin proving successful in human clinical trials

For decades researchers have worked to find a way to orally administer insulin effectively to patients with diabetes. Now this game-changing treatment is one step closer to reality, with pharmaceutical company Oramed embarking on a final Phase 2b human clinical trial to prove the efficacy of its oral insulin before moving to the final stages […]

B2B News Network: Inside The Mind Of . . . Nadav Kidron

Nadav Kidron serves as Chief Executive Officer of Oramed Pharmaceuticals, which he co-founded in 2006. Their orally-taken insulin is game-changing technology that could revolutionize the way millions people with diabetes administer their medication. Read the full article on

WKYC: Nadav Kidron-Oramed Pharmaceuticals is Changing The Lives of Diabetic Patients

Millions of diabetics inject insulin daily, and millions more are on the path to injections. But Oramed Pharmaceuticals aims to change that reality, with an insulin pill. Currently in clinical trials, the oral insulin capsule could radically change how we treat diabetes, and dramatically change the lives of diabetic patients. Oramed Pharmaceuticals CEO Nadav Kidron […]

Forbes: AI And Radar: The Future Of Noninvasive Blood Sugar Monitoring?

The “wish list”, or holy grail for diabetics who prick their finger several times a day to measure their blood sugar usually involves two things: a way to check their blood sugar without painful finger pricks, and taking a pill instead of an insulin shot. Read the full article on

Join our mailing list

Skip to content